[HTML][HTML] Molecular genomic and epigenomic characteristics related to aspirin and clopidogrel resistance
J Kim, BS Shin, DH Kim, DI Shin, SH Ahn, JG Kim… - BMC Medical …, 2024 - Springer
Background Mediators, genomic and epigenomic characteristics involving in metabolism of
arachidonic acid by cyclooxygenase (COX) and lipoxygenase (ALOX) and hepatic activation …
arachidonic acid by cyclooxygenase (COX) and lipoxygenase (ALOX) and hepatic activation …
[HTML][HTML] Molecular genomic and epigenomic characteristics related to aspirin and clopidogrel resistance
J Kim, BS Shin, DH Kim, DI Shin… - BMC Medical …, 2024 - bmcmedgenomics.biomedcentral …
Mediators, genomic and epigenomic characteristics involving in metabolism of arachidonic
acid by cyclooxygenase (COX) and lipoxygenase (ALOX) and hepatic activation of …
acid by cyclooxygenase (COX) and lipoxygenase (ALOX) and hepatic activation of …
[PDF][PDF] Molecular genomic and epigenomic characteristics related to aspirin and clopidogrel resistance
J Kim, BS Shin, DH Kim, DI Shin, SH Ahn… - 2024 - bmcmedgenomics.biomedcentral …
Background Mediators, genomic and epigenomic characteristics involving in metabolism of
arachidonic acid by cyclooxygenase (COX) and lipoxygenase (ALOX) and hepatic activation …
arachidonic acid by cyclooxygenase (COX) and lipoxygenase (ALOX) and hepatic activation …